Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
I like the majority on here would love OBD to be part of the Transform pilot, but some posts (HG44,) on here where they have received a reply today leaves me a little suspicious that there is some ramping going on here. I doubt very much anyone would be around today to answer emails.
Stop lying and keep it real.
RM Partners seem to be involved in the Pilot named Transform.
I have emailed them this evening with the following, will update you when they get back to me.
Good evening
I can see that you are part of a new screening pilot Transform, for Prostate Cancer. I'm not sure if you are aware but Oxford Biodynamics PLC has developed a blood test (PSE) that is 94% accurate as apposed to a standard PSA test.
Will you be sticking to just MRI scans or looking at alternatives.
Thank you for your time.
The trouble we have is that too many punters over expose themselves thinking they've struck gold and expect an instant profit. Any drop in share price is then magnified by them panicking out. This company has so much potential it's worth sticking with the, short term price movement, who knows. Could be down to 22p next week or at £1.22, the potential is there which makes it exciting, but would I put my life savings into it, definitely no
For an institution like this to be buying into what is basically still a penny share speaks volumes of its potential. Possible stake building for a potential takeover, who knows but the fundamentals are clearly extremely solid.
With the share price this low I would expect a lot more negative comments from disgruntled investors. Seem to be some die hards on here where the bods can do no wrong which is very confusing. Are some of the most ultra positive posts from the bods themselves. With this lot anything is possible.
Warn others in relation to the title of this post
Well the market is clearly seeing through all the bods Bullsxxt, such optimism but that doesn't stretch to them buying in. Please don't invest on what the new CFO was saying about adding to shareholder value. I would have expected them to at least acknowledge the dire share price performance over the last 9 months, but no it was the usual promising the earth drivel to entice more unsuspecting punters. Aim company and board at its worst.
They need a big pharma to step in to deal with all the manufacturer, marketing and testing. In return OBD receive on going royalties and a very large upfront payment. This would finance future work and give shareholders a regular income way into the future. I'm sure the board are working on something similar in the background
Still looking at 2nd 1/4 of 2024 for the next placement. As CJ39 has already alluded to, if the share price doesn't improve the dilution at these levels would be disastrous for existing shareholder value.
Mike - I would look on the government holding as a good thing, in my eyes they would be more than happy to sell their share to a suitable buyer and finally be rid of the whole sorry affair. With the board in limbo it's probably ripe for a takeover.
Not entirely sure what the MM are up to today, all the trades apart from the 30,000 this morning were sells, and some are completely out of the market ie around 1.8p. Market price just hasn't been that low
Well the bounce I was expecting was a bit of a damp squid so I've taken my meager profit and will buy myself a Euro millions ticket for Friday, I'm sure I'll have more luck.
P.s the 20,000 buy at 1.9501 was actually a sell.
Just like the majority of UK companies, they are unloved and out of favour. According to an Ft article this weekend even the fund that administers MPs pensions isn't going anywhere near UK stocks. Still they are literally making billions so eventually they'll bounce back up. Short term gap to £2.04 needs filling, longer term there is one at £3.01. Currently yields 7.57% with a PE of 4.07. The Coop where looking at acquisitions, and I'm sure a VC would be able to extract value, so a possible takeover is a distinct possibility.
I've always described Evgen as a never ending series that is well beyond its sell by date. At the end of each season they leave it with a cliff hanger to entice you back in but the result is always the same.
I wonder if this has enough momentum behind it to close the 3.02p gap.
Was the latest RNS the reason why the bods were advised not to buy, I can't see anything in it to suggest so. They'll definitely be challenged on the next AGM, I wonder what excuse they'll come up with then.
My understanding is that a biopsy is the ultimate test to determine if it's cancerous of not.
You start with PSA test, then MRI scan if the numbers on the PSA are elevated. If the MRI scan is a concern then they'll recommend a biopsy.
The PSE could do away with the MRI and more importantly the biopsy which really isn't a pleasant experience.
£400
But I bet the majority on here had wished they'd only staked £40
Fair comment
Seems to be some buying going on, looks big in share volume but the actual cash equivalent isn't.
Have the bods finally got round to buying, I won't hold my breath.